Abstract
Major radiotherapy centers or collaborative groups report 5-year survival rates of 80–90% or higher in patients with Stages I-IIA Hodgkin’s disease [1–4]. These results have been achieved with megavoltage equipment, variable irradiated fields (involved field to total lymphoid) and doses between 3,500 and 4,400 rad. Adjuvant chemotherapy has significantly increased relapse-free survival compared with irradiation alone (87–92% vs 66–79% at 5 years). However, 5-year survival rates are identical. Comparisons at 10 or more years remain to be determined [1, 2, 4].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hoppe RT, Coleman CN, Cox RS et al. (1982). The management of Stage I-II Hodgkin’s disease with irradiation alone or combined modality therapy: The Stanford experience. Blood 59: 455–465.
Nissen NI and Nordentoft AM (1982). Radiotherapy vs combined modality treatment of Stage I and II Hodgkin’s disease. Cancer Treat Rep 66: 799–803.
Bergsagel DE, Alison RE, Bean HA et al. (1982). Results of treating Hodgkin’s disease without a policy of laparatomy staging. Cancer Treat Rep 66: 717–731.
Andrieu JM, Montagnan B, Asselain B et al. (1980). Chemotherapy-radiotherapy association in Hodgkin’s disease, clinical Stages IA-III: Results of a prospective clinical trial with 166 patients. Cancer 46: 2126–2130.
Pavlovsky S, Morguenfeld M, Somoza N et al. (1981). Long term follow-up of two chemotherapy protocols in Hodgkin’s disease. Medicina (Buenos Aires) 41 (Supl): 15–21.
DeVita VT, Simon RM, Hubbard SM et al. (1980). Curability of advanced Hodgkin’s disease with chemotherapy long term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92: 587–595.
Kapp DS, Prosnitz LR, Farber LR et al. (1983). Patterns of failure in Hodgkin’s disease: The Yale University experience. Cancer Treat Symposia 2: 145–156.
Fuller LM and Hagemeister FB (1983). Diagnosis and management of Hodgkin’s disease in adults. Cancer 51: 2469–2476.
Olweny CLM, Katongole-Mbidde E, Kiire C et al. (1978). Childhood Hodgkin’s disease in Uganda. A ten years experience. Cancer 42: 787–792.
Ekert H and Waters KD (1983). Results of treatment of 18 children with Hodgkin’s disease with MOPP chemotherapy as the only treatment modality. Med Pediat Oncol 11: 322–326.
Jacobs P, King HS, Karahus C et al. (1984). Hodgkin’s disease in children. A ten year experience in South Africa. Cancer 53: 210–213.
Schomberg PJ, Evans RG, O’Connel MJ et al. (1984). Prognostic significance of mediastinal mass in adult Hodgkin’s disease. Cancer 53: 324–328.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Pavlovsky, S., Dupont, J., Jiménez, E., Sackmann-Muriel, F., Montero, C., Garay, G. (1985). Randomized study of chemotherapy alone vs. chemotherapy plus radiotherapy in Clinical Stages IA-IIA Hodgkin’s disease. In: Cavalli, F., Bonadonna, G., Rozencweig, M. (eds) Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances. Developments in Oncology, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2607-6_35
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2607-6_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9632-4
Online ISBN: 978-1-4613-2607-6
eBook Packages: Springer Book Archive